| surrogate marker |
Laboratory tests that may predict a patient's clinical outcome or indicate whether a drug is effective without having to rely on the traditional clinical endpoints of death or development of a major opportunistic infection. Surrogate markers under study in HIV disease include CD4 counts, CD4/CD8 cell ratios, and viral load.
출처: www.amfar.org/cgi-bin/iowa/bridge.html
|
|---|---|
| surrogate marker |
Something that indirectly reflects the patient's current clinical condition. For example, the number of T cells tells us something about how much damage HIV has done, but it is not a direct measure of how much virus is present.
출처: www.thebody.com/hivnews/aidscare/dec97/pullout.htm...
|
| surrogate marker |
an indirect measure of disease progression. In HIV disease, the number of CD4+ T cells per cubic millimeter of blood is often used as a surrogate marker.
출처: www.opendoorclinic.org/hivglossary.htm
|
| surrogate marker |
A measurement of a drug's biologic activity that substitutes for a clinical endpoint such as death or pain relief. Source: Applied Clinical Trials/Advanstar. Click for their site: www.advanstar. ...
출처: www.biotechmedia.com/definitions-s.html
|